RESEARCH MONOGRAPH · KDC-MN-184

5-HTP (5-Hydroxytryptophan)

May 9, 2026 Kodiac biolabs Research Revised May 30, 2026 2 min read

Our opinion on this compound

63/100

The precursor that skips a control point, which is exactly why it's both useful and risky

5-HTP (5-hydroxytryptophan) is the immediate precursor to serotonin, one step downstream of tryptophan in the serotonin synthesis pathway. Tryptophan hydroxylase converts L-tryptophan to 5-HTP, and aromatic amino acid decarboxylase (AAAD/DDC) then converts 5-HTP to serotonin. Supplementing 5-HTP bypasses the rate-limiting TPH step, which makes it a more direct way to raise serotonin synthesis than supplementing tryptophan.

That bypass is the entire point and also the entire concern. By skipping TPH you skip the feedback regulation, the substrate-competition control, the tissue-selective expression of TPH1 versus TPH2, and you push serotonin synthesis wherever AAAD is expressed, which is in a lot of peripheral tissues (gut enterochromaffin cells especially) and centrally.

The most-discussed concern is peripheral serotonin excess. Most of supplemental 5-HTP gets decarboxylated peripherally to serotonin before reaching the brain, with relevant downstream effects on gut motility (often unpleasant), cardiac valve concerns at chronic exposures (theoretical, drawn from the carcinoid syndrome literature where chronic peripheral serotonin excess does cause valvulopathy), and depletion of cofactors. Co-administering a peripheral AAAD inhibitor (carbidopa) is the classical research workaround, the way it's done in some Parkinson's research with 5-HTP plus carbidopa to get more centrally-active 5-HTP without the peripheral serotonin load. Without that, a lot of supplemental 5-HTP doesnt do what people think it does.

Clinical evidence is mixed. Depression trials are honestly underwhelming in modern reviews. Sleep onset effects are real at 100-300mg. Migraine prophylaxis has some signal in older European clinical literature. Fibromyalgia has small-scale support. None of it is impressive RCT-level evidence.

Sourcing: most commercial 5-HTP is extracted from Griffonia simplicifolia seeds, which contain 5-HTP naturally at high concentrations. There's some synthetic 5-HTP available. HPLC purity verification matters because Peak X impurities (the 5-HTP version of the EMS scare) have been documented historically. Reputable suppliers manage this.

Safety: real serotonin syndrome risk when combined with SSRIs, MAOIs, or other serotonergic compounds. This is not theoretical, it has happened with 5-HTP combinations.

What we like: it's a useful tool for selectively probing AAAD-dependent serotonin synthesis in research contexts, especially with co-administered peripheral inhibitors. What we dont like: most consumer 5-HTP use ignores the peripheral metabolism issue and gets a different exposure profile than the user is targeting.

Evidence: 55
Mechanism: 72
Reliability: 55
Safety: 55
Sourcing: 72
Value: 70
Signal: 65
Staying power: 60

Plain-language summary Intrigue 55 / 100

5-HTP is the immediate precursor to serotonin, one biosynthetic step closer than tryptophan. Used as a supplement for mood and sleep. Combination with B6 increases conversion efficiency. Should not be combined with serotonergic medications. Not stocked by Kodiac. This monograph is provided for research and educational reference.

Intrigue 0–100 blends mechanism novelty, evidence strength, and translational potential. Kodiac editorial, not peer-reviewed.

Serotonin precursor

5-Hydroxytryptophan, the immediate precursor of serotonin, derived from Griffonia simplicifolia seeds and used for mood and sleep applications.

Abstract

5-HTP (5-hydroxytryptophan; CAS 4350-09-8; molecular formula C11H12N2O3; molecular weight 220.23) is the immediate precursor of serotonin in the biosynthesis pathway from tryptophan. The compound is extracted from Griffonia simplicifolia seeds and sold as a dietary supplement. Unlike tryptophan, 5-HTP does not compete with other large neutral amino acids for transport into the CNS, providing more reliable elevation of central serotonin. The compound has been studied for depression, anxiety, sleep, and headache prevention. Use without a peripheral aromatic L-amino acid decarboxylase inhibitor produces peripheral serotonin elevation that may cause GI adverse events. Reported research dose ranges in the literature are described in the source publications. Should not be combined with SSRIs or MAOIs due to serotonin syndrome risk.

Mechanism of action

Direct serotonin precursor; converted to serotonin by aromatic L-amino acid decarboxylase. Bypasses tryptophan hydroxylase rate limit.

Reported research dose ranges

Reported research dose ranges in the literature.

References

Birdsall TC. 5-Hydroxytryptophan: a clinically-effective serotonin precursor. Altern Med Rev 1998.

Read the full monograph

Available as a research-use-only PDF download. Note: PDFs for newly added compounds may take a few hours to propagate after this article was published.

KDC-MN-184

The full reference document is provided strictly for research use only. It reports research dose ranges from the published literature, not instructions for use in humans or animals.

Download PDF →

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human consumption. All information is provided for research and educational purposes only.

Kodiac sells research compounds for investigative use only.

5-HTP (5-Hydroxytryptophan)

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Quick actions

Categories

Help and policies

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Adjacent monographs